CHL1 is involved in human breast tumorigenesis and progression.

Neural cell adhesion molecules (CAM) play important roles in the development and regeneration of the nervous system. The L1 family of CAMs is comprised of L1, Close Homolog of L1 (CHL1, L1CAM2), NrCAM, and Neurofascin, which are structurally related trans-membrane proteins in vertebrates. Although the L1CAM has been demonstrated play important role in carcinogenesis and progression, the function of CHL1 in human breast cancer is limited. Here, we found that CHL1 is down-regulated in human breast cancer and related to lower grade. Furthermore, overexpression of CHL1 suppresses proliferation and invasion in MDA-MB-231 cells and knockdown of CHL1 expression results in increased proliferation and invasion in MCF7 cells in vitro. Finally, CHL1 deficiency promotes tumor formation in vivo. Our results may provide a strategy for blocking breast carcinogenesis and progression.

[1]  R. D'Hooge,et al.  CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior. , 2003, Human molecular genetics.

[2]  A. Ben-Ze'ev,et al.  L1 cell adhesion molecule (L1CAM) in invasive tumors. , 2009, Cancer letters.

[3]  A. Mes-Masson,et al.  Molecular Genetic Analysis of a Cell Adhesion Molecule With Homology to L1CAM, Contactin 6, and Contactin 4 Candidate Chromosome 3p26pter Tumor Suppressor Genes in Ovarian Cancer , 2009, International Journal of Gynecologic Cancer.

[4]  J. Eisen,et al.  In silico-initiated cloning and molecular characterization of a novel human member of the L1 gene family of neural cell adhesion molecules , 1998, Human Genetics.

[5]  A. Godwin,et al.  The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. , 2008, Cancer research.

[6]  Min Liu,et al.  MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. , 2012, Cancer letters.

[7]  E. Gillanders,et al.  Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus , 2004, Human Genetics.

[8]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[9]  M. Schachner,et al.  CHL1 negatively regulates the proliferation and neuronal differentiation of neural progenitor cells through activation of the ERK1/2 MAPK pathway , 2011, Molecular and Cellular Neuroscience.

[10]  Juyeon Jung,et al.  The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo. , 2011, Oncology reports.

[11]  Richard Redon,et al.  Confirmed rare copy number variants implicate novel genes in schizophrenia. , 2010, Biochemical Society transactions.

[12]  M. Schachner,et al.  Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. , 2002, European journal of cancer.

[13]  M. Hortsch.  Structural and Functional Evolution of the L1 Family: Are Four Adhesion Molecules Better Than One? , 2000, Molecular and Cellular Neuroscience.

[14]  G. Demyanenko,et al.  CHL1 cooperates with PAK1–3 to regulate morphological differentiation of embryonic cortical neurons , 2010, Neuroscience.

[15]  S. Knapp,et al.  Targeting group II PAKs in cancer and metastasis , 2009, Cancer and Metastasis Reviews.

[16]  O. Migita,et al.  An association between a missense polymorphism in the close homologue of L1 (CHL1, CALL) gene and schizophrenia , 2002, Molecular Psychiatry.

[17]  Ian O Ellis,et al.  Prognostic markers in triple‐negative breast cancer , 2007, Cancer.

[18]  P. Altevogt,et al.  L1 augments cell migration and tumor growth but not β3 integrin expression in ovarian carcinomas , 2005, International journal of cancer.

[19]  D. Galileo,et al.  Soluble L 1 CAM promotes breast cancer cell adhesion and migration in vitro , but not invasion , 2010 .

[20]  M. Alaoui-Jamali,et al.  Molecular insights on basal-like breast cancer , 2012, Breast Cancer Research and Treatment.

[21]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  H. Kijima,et al.  L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma , 2011, Journal of surgical oncology.

[23]  H. Kamiguchi,et al.  IgCAMs: bidirectional signals underlying neurite growth. , 2000, Current opinion in cell biology.

[24]  A. Ben-Ze'ev,et al.  L1-Mediated Colon Cancer Cell Metastasis Does Not Require Changes in EMT and Cancer Stem Cell Markers , 2010, Molecular Cancer Research.

[25]  George S. Krasnov,et al.  Differential Expression of CHL1 Gene during Development of Major Human Cancers , 2011, PloS one.

[26]  M. Wei,et al.  CALL gene is haploinsufficient in a 3p- syndrome patient. , 1999, American journal of medical genetics.

[27]  A. Whale,et al.  Signalling to cancer cell invasion through PAK family kinases. , 2011, Frontiers in bioscience.

[28]  M. Schachner,et al.  A New Role for the Cell Adhesion Molecule L1 in Neural Precursor Cell Proliferation, Differentiation, and Transmitter-Specific Subtype Generation , 2003, The Journal of Neuroscience.

[29]  P. Focia,et al.  Homophilic Adhesion Mechanism of Neurofascin, a Member of the L1 Family of Neural Cell Adhesion Molecules , 2010, The Journal of Biological Chemistry.

[30]  P. Altevogt,et al.  L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers , 2005, The Journal of cell biology.

[31]  G. Kristiansen,et al.  L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer , 2011, Molecular Cancer.